These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6706980)

  • 1. Nonenzymatic glycosylation of human serum albumin alters its conformation and function.
    Shaklai N; Garlick RL; Bunn HF
    J Biol Chem; 1984 Mar; 259(6):3812-7. PubMed ID: 6706980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The principal site of nonenzymatic glycosylation of human serum albumin in vivo.
    Garlick RL; Mazer JS
    J Biol Chem; 1983 May; 258(10):6142-6. PubMed ID: 6853480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites.
    Iberg N; Flückiger R
    J Biol Chem; 1986 Oct; 261(29):13542-5. PubMed ID: 3759977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of non-enzymatic glycation in human serum albumin. Spectroscopic analysis.
    Szkudlarek A; Sułkowska A; Maciążek-Jurczyk M; Chudzik M; Równicka-Zubik J
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Jan; 152():645-53. PubMed ID: 25735846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of methemoglobin and ferricytochrome c by glycosylated amino acids and albumin.
    Stepuro II; Chaikovskaya NA; Vodoevich VP; Vinogradov VV
    Biochemistry (Mosc); 1997 Sep; 62(9):967-72. PubMed ID: 9457761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of glycation on bovine serum albumin conformation and ligand binding properties with regard to gliclazide.
    Żurawska-Płaksej E; Rorbach-Dolata A; Wiglusz K; Piwowar A
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 Jan; 189():625-633. PubMed ID: 28888191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of non-enzymatic glycosylation of human serum albumin using ion trap-time of flight mass spectrometry.
    Bai X; Wang Z; Huang C; Wang Z; Chi L
    Molecules; 2012 Jul; 17(8):8782-94. PubMed ID: 22832880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective ability and binding affinity of captopril towards serum albumin in an in vitro glycation model of diabetes mellitus.
    Mariee AD; Al-Shabanah O
    J Pharm Biomed Anal; 2006 May; 41(2):571-5. PubMed ID: 16469467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver and kidney tissue membranes as tissue markers for nonenzymatic glycosylation.
    Cefalu WT; Wang ZQ; Bell-Farrow A; Ralapati S
    Diabetes; 1991 Jul; 40(7):902-7. PubMed ID: 2060726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorometric and mass spectrometric analysis of nonenzymatic glycosylated albumin.
    Zoellner H; Hou JY; Hochgrebe T; Poljak A; Duncan MW; Golding J; Henderson T; Lynch G
    Biochem Biophys Res Commun; 2001 Jun; 284(1):83-9. PubMed ID: 11374874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diabetes mellitus and the transport function of glycosylated and nonglycosylated albumin].
    Galenok VA; Dikker VE; Khanykina IV
    Ter Arkh; 1990; 62(1):108-11. PubMed ID: 2185572
    [No Abstract]   [Full Text] [Related]  

  • 12. Spectroscopic studies of the effects of glycation of human serum albumin on L-Trp binding.
    Barzegar A; Moosavi-Movahedi AA; Sattarahmady N; Hosseinpour-Faizi MA; Aminbakhsh M; Ahmad F; Saboury AA; Ganjali MR; Norouzi P
    Protein Pept Lett; 2007; 14(1):13-8. PubMed ID: 17266645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adducts of glycosylated serum albumin with amino acids].
    Stepuro II; Piletskaia TP; Iaroshevich NA; Naumov AV
    Ukr Biokhim Zh (1978); 1986; 58(4):9-14. PubMed ID: 3739039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorometric measurement of glycosylated albumin in human serum.
    Hayashi Y; Makino M
    Clin Chim Acta; 1985 Jun; 149(1):13-9. PubMed ID: 4028431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sialic acid on glycation-induced fluorescence of albumin.
    Lipovac V; Gavella M; Sverko V
    Acta Diabetol; 1994 Sep; 31(3):156-9. PubMed ID: 7827355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonenzymatic glycosylation of human serum albumin and its effect on antibodies profile in patients with diabetes mellitus.
    Raghav A; Ahmad J; Alam K
    PLoS One; 2017; 12(5):e0176970. PubMed ID: 28520799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nonenzymatic glycation and fatty acids on functional properties of human albumin.
    Lautenslager GT; Shearman CW; Hud E; Cohen MP
    Metabolism; 2011 Dec; 60(12):1683-91. PubMed ID: 21632076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased permeability across the blood-nerve barrier of albumin glycated in vitro and in vivo from patients with diabetic polyneuropathy.
    Poduslo JF; Curran GL
    Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2218-22. PubMed ID: 1549585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nonenzymatic glycosylation and fatty acids on tryptophan binding to human serum albumin.
    Bohney JP; Feldhoff RC
    Biochem Pharmacol; 1992 Apr; 43(8):1829-34. PubMed ID: 1575775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Piracetam on Gliclazide-Glycated Human Serum Albumin Interaction. A Spectrofluorometric Study.
    Szkudlarek A; Pożycka J; Maciążek-Jurczyk M
    Molecules; 2018 Dec; 24(1):. PubMed ID: 30597970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.